Lung cancer circulating tumor cells isolated by the EpCAM-independent enrichment strategy correlate with Cytokeratin 19-derived CYFRA21-1 and pathological staging.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinica chimica acta; international journal of clinical chemistry

• Publication date

  2013-04-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.cca.2013.01.015PMID 23415723
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis.

  2012cited by this paper
• Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood

  2011cited by this paper
• Circulating tumor cells: approaches to isolation and characterization

  2011cited by this paper
• Tumorigenesis and Neoplastic Progression Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy

  2010cited by this paper
• Circulating endothelial and endothelial progenitor cells in non-small-cell lung cancer

  2010cited by this paper
• 血清细胞角蛋白19在预测进展期非小细胞肺癌患者化疗疗效及预后中的临床意义

  2010cited by this paper
• Toward unraveling the complexity of simple epithelial keratins in human disease.

  2009cited by this paper
• Preliminary Investigation of the Clinical Significance of Detecting Circulating Tumor Cells Enriched from Lung Cancer Patients

  2009cited by this paper
• Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer

  2009cited by this paper
• Circulating Cytokeratin 19 Fragments in Patients with benign Nodules and Carcinomas of the Thyroid Gland

  2008cited by this paper
• Circulating cytokeratin 19 fragments in patients with benign nodules and carcinomas of the thyroid gland.

  2008cited by this paper
• Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer.

  2007cited by this paper
• American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

  2007cited by this paper
• Cytokeratin Markers Come of Age

  2007cited by this paper
• Circulating tumor cells (CTC) detection: clinical impact and future directions.

  2007cited by this paper
• Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer

  2006cited by this paper
• Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival

  2006cited by this paper
• Calnuc binds to Alzheimer’s β‐amyloid precursor protein and affects its biogenesis

  2006cited by this paper
• Cancer Statistics, 2006

  2006cited by this paper
• Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer

  2006cited by this paper
• Circulating and disseminated tumor cells.

  2005cited by this paper
• Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.

  2005cited by this paper
• CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy

  2004cited by this paper
• CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients

  2004cited by this paper
• Down-Regulated Expression of Cytokeratin 18 Promotes Progression of Human Breast Cancer

  2004cited by this paper
• Frequent EpCam protein expression in human carcinomas.

  2004cited by this paper
• Dissecting the metastatic cascade

  2004cited by this paper
• Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

  2004cited by this paper
• Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

  2004cited by this paper
• Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer.

  2002cited by this paper
• The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21‐1) in human lung cancer cell lines

  2001cited by this paper
• Calnuc, an EF-hand Ca(2+) binding protein, specifically interacts with the C-terminal alpha5-helix of G(alpha)i3.

  2000cited by this paper
• Calnuc, an EF-Hand Ca2+ binding protein, specifically interacts with the C-terminal α5-helix of Gαi3

  2000cited by this paper
• Clinical value of CYFRA 21.1, carcinoembryonic antigen, neurone-specific enolase, tissue polypeptide specific antigen and tissue polypeptide antigen in the diagnosis of lung cancer.

  1997cited by this paper
• Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role.

  1995cited by this paper
• Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies.

  1988cited by this paper

• CTC-Race: Single-Cell Motility Assay of Circulating Tumor Cells from Metastatic Lung Cancer Patients

  2024cites this paper
• Identification of biomarkers for the early detection of non-small cell lung cancer: a systematic review and meta-analysis.

  2023cites this paper
• Highly Mimetic Ex Vivo Lung‐Cancer Spheroid‐Based Physiological Model for Clinical Precision Therapeutics

  2023cites this paper
• Liquid biopsy in lung cancer management

  2022influential citation
• Bronchoalveolar Lavage Fluid-Isolated Biomarkers for the Diagnostic and Prognostic Assessment of Lung Cancer

  2022cites this paper
• Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules

  2022cites this paper
• Clinical significance of circulating tumour cells and tumour marker detection in the chemotherapeutic evaluation of advanced colorectal cancer

  2021cites this paper
• Tumour burden and efficacy of immune-checkpoint inhibitors

  2021cites this paper
• Photocatalytic electrochemical sensor based on three-dimensional graphene nanocomposites for the ultrasensitive detection of CYFRA21-1 gene

  2021cites this paper
• Clinical Utility of Circulating Tumor Cells in the Early Detection of Lung Cancer in Patients with a Solitary Pulmonary Nodule

  2021cites this paper
• Diagnostic Value of the Circulating Tumor Cells and Circulating Tumor-Derived Endothelial Cells Detection for Non-Small Cell Lung Cancer

  2021cites this paper
• An ultrasensitive ratiometric immunosensor based on the ratios of conjugated distyrylbenzene derivative nanosheets with AIECL properties and electrochemical signal for CYFRA21-1 detection

  2021cites this paper
• Electrochemical CYFRA21-1 DNA sensor with PCR-like sensitivity based on AgNPs and cascade polymerization

  2020cites this paper
• F-containing initiatior for ultrasensitive fluorescent detection of lung cancer DNA via atom transfer radical polymerization.

  2020cites this paper
• Liquid Biopsy Analysis of Circulating Tumor Biomarkers in Lung Cancer

  2020cites this paper
• Correlation of pulmonary venous circulating tumor cells with clinicopathological parameters in patients with early-stage lung adenocarcinoma

  2019cites this paper
• Preliminary study of SET-iFISH technology in detecting circulating tumor cells in renal cell carcinoma

  2019cites this paper
• Circulating Tumor Cell Number Is Associated with Primary Tumor Volume in Patients with Lung Adenocarcinoma

  2019cites this paper
• Circulating tumor cells as a potential biomarker in diagnosis of lung cancer: a systematic review and meta‐analysis

  2018cites this paper
• Three-dimensional electrochemical DNA biosensor based on 3D graphene-Ag nanoparticles for sensitive detection of CYFRA21-1 in non-small cell lung cancer

  2018cites this paper
• Performance evaluation of detecting circulating tumor cells and tumor cells in bronchoalveolar lavage fluid in diagnosis of peripheral lung cancer.

  2018cites this paper
• Comprehensive in situ co-detection of aneuploid circulating endothelial and tumor cells

  2017cites this paper
• Systematic Correlation Analyses of Circulating Tumor Cells with Clinical Variables and Tumor Markers in Lung Cancer Patients

  2017cites this paper
• A liquid biopsy-based method for the detection and quantification of circulating tumor cells in surgical osteosarcoma patients

  2017cites this paper
• Screening of specific nucleic acid aptamers binding tumor markers in the serum of the lung cancer patients and identification of their activities

  2017cites this paper
• Molecular characterization of circulating tumor cells in lung cancer: moving beyond enumeration

  2017cites this paper
• Detection of circulating tumor cells in patients with non-small cell lung cancer using a size-based platform.

  2017cites this paper
• Diagnostic performance of circulating tumor cells in lung cancer : a systematic review and meta-analysis

  2017influential citation
• Combined Cardiac and Thoracic Surgery

  2017cites this paper
• Peroxidase-Like Activity of Ethylene Diamine Tetraacetic Acid and Its Application for Ultrasensitive Detection of Tumor Biomarkers and Circular Tumor Cells.

  2017cites this paper
• Analysis of circulating tumor cells from lung cancer patients with multiple biomarkers using high-performance size-based microfluidic chip

  2016cites this paper
• Emerging molecular basis of hematogenous metastasis in gastric cancer.

  2016cites this paper
• High Performance, Multiplexed Lung Cancer Biomarker Detection on a Plasmonic Gold Chip

  2016cites this paper
• Evaluation of Circulating Tumor Cells in Predicting Therapeutic Response in Small Cell Lung Cancer Patients.

  2016cites this paper
• Predictive and prognostic value of circulating tumor cell detection in lung cancer: a clinician's perspective.

  2015cites this paper
• Diagnostic Utility of Serum Cytokeratin Fragment 21-1 in Patients with Lung Cancer

  2015cites this paper
• Molecular histology of lung cancer: from targets to treatments.

  2015cites this paper
• 循环肿瘤标志物在肺癌中的应用

  2015cites this paper
• The Effects of Different Surgical Approaches on the Perioperative Level of Circulating Tumor Cells in Patients with Non-Small Cell Lung Cancer

  2015cites this paper
• Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer

  2015cites this paper
• Gene Knockdown by EpCAM Aptamer–siRNA Chimeras Suppresses Epithelial Breast Cancers and Their Tumor-Initiating Cells

  2015cites this paper
• Circulating Tumor Cells in Lung Cancer: Detection Methods and Clinical Applications

  2015cites this paper
• Molecular profiling and companion diagnostics: where is personalized medicine in cancer heading?

  2014cites this paper
• Analysis of the Discriminative Methods for Diagnosis of Benign and Malignant Solitary Pulmonary Nodules Based on Serum Markers

  2014cites this paper
• Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway.

  2014cites this paper
• Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization.

  2014cites this paper
• Effect of circulating tumor cells combined with negative enrichment and CD45-FISH identification in diagnosis, therapy monitoring and prognosis of primary lung cancer

  2014influential citation